Stock Scorer

Pacific Health Care Organization Inc (PFHO)

Pacific Health Care Organization Inc reported revenue of 1.8M USD for the quarter ending 30 June 2026, up 2.8% from 1.7M a year earlier.

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than filled in. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD. The same series drawn ›

As last reported

The newest period the filing supports for each figure, in USD.
FigurePeriodAmountYear on year
Revenue Q2 '26 · ending 30 June 2026 1.8M +2.8%
Operating Income Q2 '26 · ending 30 June 2026 369.4K +21.7%
Net Income Q2 '26 · ending 30 June 2026 327K -48.7%
Operating Cash Flow Q2 '26 · ending 30 June 2026 -5.2K -101.2%
Free Cash Flow Q2 '26 · ending 30 June 2026 -9.8K -102.1%
Shares Outstanding Q2 '26 · ending 30 June 2026 12.8M +0.0%
EPS Q2 '26 · ending 30 June 2026 0.09 -10.0%

Revenue and profit by financial year

As filed, in USD. A year the filing does not support is not listed.
YearEnding RevenueOperating IncomeNet IncomeFree Cash Flow
20252025-12-31 6.7M1M1.4M1.1M
20242024-12-31 6.1M852.6K883.6K666K
20232023-12-31 5.6M678.5K767.9K914.8K
20222022-12-31 5.7M666.1K492.9K672.4K
20212021-12-31 5.4M516.5K995K368K
20202020-12-31 6M820.3K549.6K933.6K
20192019-12-31 7.3M1.7M1.2M1M
20182018-12-31 6.8M1.9M1.4M1.3M
20172017-12-31 6.5M1.7M964.4K809.5K
20162016-12-31 5.7M969.3K566.7K1.2M

Every period

Revenue Quarterly

PeriodEndingRevenue
Q2 '262026-06-301.8M
Q1 '262026-03-311.5M
Q4 '252025-12-311.6M
Q3 '252025-09-301.6M
Q2 '252025-06-301.7M
Q1 '252025-03-311.8M
Q4 '242024-12-311.6M
Q3 '242024-09-301.5M
Q2 '242024-06-301.5M
Q1 '242024-03-311.4M
Q4 '232023-12-311.6M
Q3 '232023-09-301.4M
Q2 '232023-06-301.3M
Q1 '232023-03-311.3M
Q4 '222022-12-311.5M
Q3 '222022-09-301.5M
Q2 '222022-06-301.4M
Q1 '222022-03-311.4M
Q4 '212021-12-311.4M
Q3 '212021-09-301.3M

Operating Income Quarterly

PeriodEndingOperating Income
Q2 '262026-06-30369.4K
Q1 '262026-03-31172.7K
Q4 '252025-12-31178K
Q3 '252025-09-30205K
Q2 '252025-06-30303.6K
Q1 '252025-03-31314.4K
Q4 '242024-12-31333.9K
Q3 '242024-09-30151.6K
Q2 '242024-06-30192K
Q1 '242024-03-31175.2K
Q4 '232023-12-31304K
Q3 '232023-09-30147K
Q2 '232023-06-30145.1K
Q1 '232023-03-3182.5K
Q3 '222022-09-30266.9K
Q2 '222022-06-30173.1K
Q1 '222022-03-31262.1K
Q4 '212021-12-31157.4K
Q3 '212021-09-30106.8K
Q2 '212021-06-30131.7K

Net Income Quarterly

PeriodEndingNet Income
Q2 '262026-06-30327K
Q1 '262026-03-31193.7K
Q4 '252025-12-31235.1K
Q3 '252025-09-30223K
Q2 '252025-06-30636.9K
Q1 '252025-03-31292.7K
Q4 '242024-12-31295.8K
Q3 '242024-09-30174.9K
Q2 '242024-06-30215.6K
Q1 '242024-03-31197.4K
Q4 '232023-12-31281.3K
Q3 '232023-09-30179.1K
Q2 '232023-06-30176.4K
Q1 '232023-03-31131.1K
Q4 '222022-12-31-12.2K
Q3 '222022-09-30192K
Q2 '222022-06-30124.5K
Q1 '222022-03-31188.5K
Q4 '212021-12-31316.2K
Q3 '212021-09-3076.8K

Operating Cash Flow Quarterly

PeriodEndingOperating Cash Flow
Q2 '262026-06-30-5.2K
Q1 '262026-03-31228K
Q4 '252025-12-31351.1K
Q3 '252025-09-3023.9K
Q2 '252025-06-30455.1K
Q1 '252025-03-31330.7K
Q4 '242024-12-31568K
Q3 '242024-09-30-36.5K
Q2 '242024-06-30-147.3K
Q1 '242024-03-31290.9K
Q4 '232023-12-31501K
Q3 '232023-09-30164.6K
Q2 '232023-06-30308.2K
Q1 '232023-03-31-41.4K
Q4 '222022-12-31138.9K
Q3 '222022-09-30231.9K
Q2 '222022-06-30-118.9K
Q1 '222022-03-31459.4K
Q4 '212021-12-31-63.6K
Q3 '212021-09-3061.3K

Free Cash Flow Quarterly

Operating cash flow minus capital expenditure.

PeriodEndingFree Cash Flow
Q2 '262026-06-30-9.8K
Q1 '262026-03-31228K
Q4 '252025-12-31337.2K
Q3 '252025-09-3023K
Q2 '252025-06-30455.1K
Q1 '252025-03-31322.2K
Q4 '242024-12-31566.3K
Q3 '242024-09-30-38.2K
Q2 '242024-06-30-149.3K
Q1 '242024-03-31287.2K
Q4 '232023-12-31487.6K
Q3 '232023-09-30162K
Q2 '232023-06-30306.9K
Q1 '232023-03-31-41.6K
Q4 '222022-12-31117.7K
Q3 '222022-09-30231.4K
Q2 '222022-06-30-130K
Q1 '222022-03-31453.2K
Q4 '212021-12-31-69.8K
Q3 '212021-09-3054.5K

Shares Outstanding Quarterly

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

PeriodEndingShares Outstanding
Q2 '262026-06-3012.8M
Q1 '262026-03-3112.8M
Q3 '252025-09-3012.8M
Q2 '252025-06-3012.8M
Q1 '252025-03-3112.8M
Q3 '242024-09-3012.8M
Q2 '242024-06-3012.8M
Q1 '242024-03-3112.8M
Q3 '232023-09-3012.8M
Q2 '232023-06-3012.8M
Q1 '232023-03-3112.8M
Q3 '222022-09-3012.8M
Q2 '222022-06-3012.8M
Q1 '222022-03-3112.8M
Q3 '212021-09-3012.8M
Q2 '212021-06-3012.8M
Q1 '212021-03-3112.8M
Q3 '202020-09-3012.8M
Q2 '202020-06-3012.8M
Q1 '202020-03-3112.8M

EPS TTM

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.

PeriodEndingEPS
Q2 '262026-06-300.09
Q1 '262026-03-310.11
Q4 '252025-12-310.11
Q3 '252025-09-300.11
Q2 '252025-06-300.10
Q1 '252025-03-310.07
Q4 '242024-12-310.07
Q3 '242024-09-300.07
Q2 '242024-06-300.07
Q1 '242024-03-310.06
Q4 '232023-12-310.05
Q3 '232023-09-300.03
Q2 '232023-06-300.03
Q1 '232023-03-310.03
Q4 '222022-12-310.03
Q3 '222022-09-300.06
Q2 '222022-06-300.06
Q1 '222022-03-310.06
Q4 '212021-12-310.09
Q3 '212021-09-300.07